Active Screening of Intestinal Colonization of Carbapenem-Resistant Enterobacteriaceae for Subsequent Bloodstream Infection in Allogeneic Hematopoietic Stem Cell Transplantation

References

• Xu LP, Lu PH, Wu DP, et al.; Chinese Blood and Marrow Transplantation Registry Group. Hematopoietic stem cell transplantation activity in China 2019: a report from the Chinese Blood and Marrow Transplantation Registry Group. Bone Marrow Transplant. 2021;56(12):2940–2947. doi:10.1038/s41409-021-01431-6
   PubMed Web of Science ®Google Scholar
• Sahin U, Toprak SK, Atilla PA, Atilla E, Demirer T. An overview of infectious complications after allogeneic hematopoietic stem cell transplantation. J Infect Chemother. 2016;22(8):505–514. doi:10.1016/j.jiac.2016.05.006
   PubMed Web of Science ®Google Scholar
• D’Souza A, Fretham C, Lee SJ, et al. Current use of and trends in hematopoietic cell transplantation in the United States. Biol Blood Marrow Transplant. 2020;26(8):e177–e182. doi:10.1016/j.bbmt.2020.04.013
   PubMed Web of Science ®Google Scholar
• van Duin D. Carbapenem-resistant enterobacteriaceae: what we know and what we need to know. Virulence. 2017;8(4):379–382. doi:10.1080/21505594.2017.1306621
   PubMed Web of Science ®Google Scholar
• Yan L, Sun J, Xu X, Huang S. Epidemiology and risk factors of rectal colonization of carbapenemase-producing enterobacteriaceae among high-risk patients from ICU and HSCT wards in a university hospital. Antimicrob Resist Infect Control. 2020;9(1):155. doi:10.1186/s13756-020-00816-4
   Web of Science ®Google Scholar
• Kikuchi M, Akahoshi Y, Nakano H, et al. Risk factors for pre- and post-engraftment bloodstream infections after allogeneic hematopoietic stem cell transplantation. Transpl Infect Dis. 2015;17(1):56–65. doi:10.1111/tid.12345
   PubMed Web of Science ®Google Scholar
• Mikulska M, Raiola AM, Galaverna F, et al. Pre-engraftment bloodstream infections after allogeneic hematopoietic cell transplantation: impact of T cell-replete transplantation from a haploidentical donor. Biol Blood Marrow Transplant. 2018;24(1):109–118. doi:10.1016/j.bbmt.2017.08.024
   PubMed Web of Science ®Google Scholar
• Youssef A, Hafez H, Madney Y, et al. Incidence, risk factors, and outcome of blood stream infections during the first 100 days post-pediatric allogeneic and autologous hematopoietic stem cell transplantations. Pediatr Transplant. 2020;24(1):e13610. doi:10.1111/petr.13610
   PubMed Web of Science ®Google Scholar
• Cao W, Guan L, Li X, et al. Clinical analysis of bloodstream infections during agranulocytosis after allogeneic hematopoietic stem cell transplantation. Infect Drug Resist. 2021;14:185–192. doi:10.2147/IDR.S280869
   PubMed Web of Science ®Google Scholar
• Mikulska M, Del Bono V, Bruzzi P, et al. Mortality after bloodstream infections in allogeneic haematopoietic stem cell transplant (HSCT) recipients. Infection. 2012;40(3):271–278. doi:10.1007/s15010-011-0229-y
   PubMed Web of Science ®Google Scholar
• Stoma I, Karpov I, Milanovich N, Uss A, Iskrov I. Risk factors for mortality in patients with bloodstream infections during the pre-engraftment period after hematopoietic stem cell transplantation. Blood Res. 2016;51(2):102–106. doi:10.5045/br.2016.51.2.102
   PubMedGoogle Scholar
• Zhu Y, Xiao T, Wang Y, et al. Socioeconomic burden of bloodstream infections caused by carbapenem-resistant enterobacteriaceae. Infect Drug Resist. 2021;14:5385–5393. doi:10.2147/IDR.S341664
   PubMed Web of Science ®Google Scholar
• Gao Y, Chen M, Cai M, et al. An analysis of risk factors for carbapenem-resistant enterobacteriaceae infection. J Glob Antimicrob Resist. 2022;30:191–198. doi:10.1016/j.jgar.2022.04.005
   Web of Science ®Google Scholar
• Dickstein Y, Edelman R, Dror T, Hussein K, Bar-Lavie Y, Paul M. Carbapenem-resistant Enterobacteriaceae colonization and infection in critically ill patients: a retrospective matched cohort comparison with non-carriers. J Hosp Infect. 2016;94(1):54–59. doi:10.1016/j.jhin.2016.05.018
   PubMed Web of Science ®Google Scholar
• Tamburini FB, Andermann TM, Tkachenko E, Senchyna F, Banaei N, Bhatt AS. Precision identification of diverse bloodstream pathogens in the gut microbiome. Nat Med. 2018;24(12):1809–1814. doi:10.1038/s41591-018-0202-8
   PubMed Web of Science ®Google Scholar
• Gorrie CL, Mirceta M, Wick RR, et al. Gastrointestinal carriage is a major reservoir of Klebsiella pneumoniae infection in intensive care patients. Clin Infect Dis. 2017;65(2):208–215. doi:10.1093/cid/cix270
   PubMed Web of Science ®Google Scholar
• Woods GL, Brown-Elliott BA, Conville PS, et al. Susceptibility Testing of Mycobacteria, Nocardiae, and Other Aerobic Actinomycetes. 2nd ed. Wayne (PA): Clinical and Laboratory Standards Institute; 2011.
   Google Scholar
• Lee YT, Huang TW, Liu IF, et al. The prediction values of carbapenemase detection methods and carbapenem susceptibility testing for clinical outcomes of patients with Acinetobacter bacteremia under carbapenem treatment. J Microbiol Immunol Infect. 2022;55(2):257–265. doi:10.1016/j.jmii.2021.03.013
   Google Scholar
• Zuckerman T, Benyamini N, Sprecher H, et al. SCT in patients with carbapenem resistant Klebsiella pneumoniae: a single center experience with oral gentamicin for the eradication of carrier state. Bone Marrow Transplant. 2011;46(9):1226–1230. doi:10.1038/bmt.2010.279
   PubMed Web of Science ®Google Scholar
• Zeng Q, Xiang B, Liu Z. Profile and antibiotic pattern of blood stream infections of patients receiving hematopoietic stem cell transplants in Southwest China. Infect Drug Resist. 2022;15:2045–2054. doi:10.2147/IDR.S358926
   PubMed Web of Science ®Google Scholar
• Satlin MJ, Walsh TJ. Multidrug-resistant enterobacteriaceae, pseudomonas aeruginosa, and vancomycin-resistant enterococcus: three major threats to hematopoietic stem cell transplant recipients. Transpl Infect Dis. 2017;19(6):e12762. doi:10.1111/tid.12762
   Web of Science ®Google Scholar
• Sahitya DSK, Jandiyal A, Jain A, et al. Prevention and management of carbapenem-resistant Enterobacteriaceae in haematopoietic cell transplantation. Ther Adv Infect Dis. 2021;8:20499361211053480. doi:10.1177/20499361211053480
   Web of Science ®Google Scholar
• Stoma I, Littmann ER, Peled JU, et al. Compositional flux within the intestinal microbiota and risk for bloodstream infection with gram-negative bacteria. Clin Infect Dis. 2021;73(11):e4627–e4635. doi:10.1093/cid/ciaa068
   PubMed Web of Science ®Google Scholar
• Petrosillo N, Giannella M, Lewis R, Viale P. Treatment of carbapenem-resistant Klebsiella pneumoniae: the state of the art. Expert Rev Anti Infect Ther. 2013;11(2):159–177. doi:10.1586/eri.12.162
   PubMed Web of Science ®Google Scholar
• Ben-David D, Maor Y, Keller N, et al. Potential role of active surveillance in the control of a hospital-wide outbreak of carbapenem-resistant Klebsiella pneumoniae infection. Infect Control Hosp Epidemiol. 2010;31(6):620–626. doi:10.1086/652528
   PubMed Web of Science ®Google Scholar
• Narimatsu H, Kami M, Miyakoshi S, et al. Value of pretransplant screening for colonization of Pseudomonas aeruginosa in reduced-intensity umbilical cord blood transplantation for adult patients. Ann Hematol. 2007;86(6):449–451. doi:10.1007/s00277-007-0260-3
   Web of Science ®Google Scholar
• Nesher L, Rolston KV, Shah DP, et al. Fecal colonization and infection with Pseudomonas aeruginosa in recipients of allogeneic hematopoietic stem cell transplantation. Transpl Infect Dis. 2015;17(1):33–38. doi:10.1111/tid.12323
   PubMed Web of Science ®Google Scholar
• Young BE, Lye DC, Krishnan P, Chan SP, Leo YS. A prospective observational study of the prevalence and risk factors for colonization by antibiotic resistant bacteria in patients at admission to hospital in Singapore. BMC Infect Dis. 2014;14(1):298. doi:10.1186/1471-2334-14-298
   Web of Science ®Google Scholar
• Nordmann P, Dortet L, Poirel L. Carbapenem resistance in enterobacteriaceae: here is the storm! Trends Mol Med. 2012;18(5):263–272. doi:10.1016/j.molmed.2012.03.003
   PubMed Web of Science ®Google Scholar
• Yang TT, Luo XP, Yang Q, et al. Different screening frequencies of carbapenem-resistant enterobacteriaceae in patients undergoing hematopoietic stem cell transplantation: which one is better? Antimicrob Resist Infect Control. 2020;9(1):49. doi:10.1186/s13756-020-0706-0
   Web of Science ®Google Scholar
• Huang XL, Wu SH, Shi PF, et al. [Active screening of intestinal carbapenem-resistant enterobacteriaceae in high-risk patients admitted to the hematology wards and its effect evaluation]. Zhonghua Xue Ye Xue Za Zhi. 2020;41(11):932–936. Chinese. doi:10.3760/cma.j.issn.0253-2727.2020.11.009
   Google Scholar
• Pang F, Jia XQ, Zhao QG, Zhang Y. Factors associated to prevalence and treatment of carbapenem-resistant Enterobacteriaceae infections: a seven years retrospective study in three tertiary care hospitals. Ann Clin Microbiol Antimicrob. 2018;17(1):13. doi:10.1186/s12941-018-0267-8
   PubMed Web of Science ®Google Scholar
• Bilavsky E, Schwaber MJ, Carmeli Y. How to stem the tide of carbapenemase-producing enterobacteriaceae?: proactive versus reactive strategies. Curr Opin Infect Dis. 2010;23(4):327–331. doi:10.1097/QCO.0b013e32833b3571
   PubMed Web of Science ®Google Scholar
• Girmenia C, Rossolini GM, Piciocchi A, et al.; Gruppo Italiano Trapianto Midollo Osseo (GITMO); Gruppo Italiano Trapianto Midollo Osseo GITMO. Infections by carbapenem-resistant Klebsiella pneumoniae in SCT recipients: a nationwide retrospective survey from Italy. Bone Marrow Transplant. 2015;50(2):282–288. doi:10.1038/bmt.2014.231
   PubMed Web of Science ®Google Scholar
• Demiraslan H, Cevahir F, Berk E, Metan G, Cetin M, Alp E. Is surveillance for colonization of carbapenem-resistant gram-negative bacteria important in adult bone marrow transplantation units? Am J Infect Control. 2017;45(7):735–739. doi:10.1016/j.ajic.2017.01.006
   PubMed Web of Science ®Google Scholar
• Pouch SM, Satlin MJ. Carbapenem-resistant enterobacteriaceae in special populations: solid organ transplant recipients, stem cell transplant recipients, and patients with hematologic malignancies. Virulence. 2017;8(4):391–402. doi:10.1080/21505594.2016.1213472
   PubMed Web of Science ®Google Scholar
• Satlin MJ, Cohen N, Ma KC, et al. Bacteremia due to carbapenem-resistant enterobacteriaceae in neutropenic patients with hematologic malignancies. J Infect. 2016;73(4):336–345. doi:10.1016/j.jinf.2016.07.002
   PubMed Web of Science ®Google Scholar
• Satlin MJ, Calfee DP, Chen L, et al. Emergence of carbapenem-resistant enterobacteriaceae as causes of bloodstream infections in patients with hematologic malignancies. Leuk Lymphoma. 2013;54(4):799–806. doi:10.3109/10428194.2012.723210
   PubMed Web of Science ®Google Scholar
• Liang Q, Chen J, Xu Y, Chen Y, Huang M. Active surveillance of carbapenem-resistant gram-negative bacteria to guide antibiotic therapy: a single-center prospective observational study. Antimicrob Resist Infect Control. 2022;11(1):89. doi:10.1186/s13756-022-01103-0
   Web of Science ®Google Scholar